Related Experiment Video

Updated: Aug 19, 2026

Three-Dimensional (3D) Tumor Spheroid Invasion Assay
12:19

Three-Dimensional (3D) Tumor Spheroid Invasion Assay

Published on: May 1, 2015

STAT 3 activation in head and neck squamous cell carcinomas is controlled by the EGFR

Markus Hambek1, Mehran Baghi, Klaus Strebhardt

  • 1Department of Otorhinolaryngology, School of Medicine, J. W. Goethe University, 60590 Frankfurt, Germany.

Anticancer Research
|March 2, 2005
PubMed

Insights

Blocking the epidermal growth factor receptor (EGFR) effectively inhibits signal transducer and activator of transcription 3 (STAT 3) activation in head and neck squamous cell carcinoma. This suggests EGFR is a viable target for controlling SCCHN proliferation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Squamous cell carcinoma of the head and neck (SCCHN) proliferation is linked to epidermal growth factor receptor (EGFR) expression.
  • Signal transducer and activator of transcription 3 (STAT 3) activation also drives SCCHN cell growth, making its interaction with EGFR a key therapeutic target.

Purpose of the Study:

  • To investigate the impact of epidermal growth factor receptor (EGFR) modulation on signal transducer and activator of transcription 3 (STAT 3) activation in SCCHN.
  • To compare the effects of EGFR regulation on STAT 3 activation versus the MAP Kinase pathway.

Main Methods:

  • Utilized human SCCHN cell lines and in vivo tumor models.
  • Administered EGFR blocking and activating agents.
  • Assessed STAT 3 activation and MAP Kinase pathway regulation.

Main Results:

  • EGFR blocking significantly inhibited STAT 3 activation both in vitro and in vivo.
  • EGFR modulation had minimal impact on the MAP Kinase pathway.

Conclusions:

  • Signal transducer and activator of transcription 3 (STAT 3) activity, crucial for SCCHN proliferation, can be effectively controlled by targeting the epidermal growth factor receptor (EGFR).
  • EGFR represents a promising therapeutic target for managing head and neck squamous cell carcinoma.

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...